RomneeSClarkMD
Oncology • Indianapolis, INGastrointestinal Cancer, Head & Neck Cancer, Hematologic Oncology
Associate Professor, Medicine, Indiana University School of Medicine
Dr. Clark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 Barnhill Dr
# ROUTE473
Indianapolis, IN 46202Phone+1 317-278-7576
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1995 - 1998
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1994 - 1994
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1991 - 1994
Indiana University School of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 1999 - 2017
Clinical Trials
- Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2006 Sep 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
- A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsPemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group.Shadia I. Jalal, David Waterhouse, Martin J. Edelman, Sreenivasa Nattam, Rafat Ansari
Journal of Thoracic Oncology. 2009-11-01 - 12 citationsPhase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular CarcinomaSafi Shahda, Patrick J. Loehrer, Romnee Clark, A. John Spittler, Sandra K. Althouse
The Oncologist. 2016-06-01 - 25 citationsPhase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.E. Gabriela Chiorean, Bryan P. Schneider, Fatih Akisik, Susan M. Perkins, Stephen C. Anderson
International Journal of Radiation Oncology, Biology, Physics. 2014-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
